Loading...
By the Editors
This week, the CDC shortened the postexposure quarantine period for COVID-19 to as few as 7 days in some circumstances. Elsewhere, Moderna filed for emergency use authorization for its vaccine in the U.S., and CDC advisers voted nearly unanimously that healthcare providers and residents of long-term-care facilities should be prioritized once a vaccine becomes available. Meanwhile, in the U.K., health regulators authorized Pfizer's COVID-19 vaccine. And back in the U.S., the CDC updated its travel guidance, recommending pre- and post-travel SARS-CoV-2 testing for those who choose to venture about. Catch up on these and all of our COVID-19 stories from the past week at the links below.
Comment
LINK(S):
COVID-19: Durable Vaccine Response / Overdose-Related Cardiac Arrests (Dec. 3) (Free)
CDC Shortens COVID-19 Quarantine Time, Sets New Travel Guidance (Dec. 2) (Free)
COVID-19: 1st Vaccine OK'ed in U.K. / Vaccine Study in Teens / Insufficient Evidence for Casirivimab + Imdevimab (Dec. 2) (Free)
COVID-19: CDC Advisers Vote on Vaccine Allocation / Immunosuppression & Viral Shedding / Multidrug-Resistant Organisms (Dec. 1) (Free)
COVID-19: Moderna Requests Vaccine Authorization / MIS-C Racial Differences / Severe Lung Damage (Nov. 30) (Free)
COVID-19: Shorter Isolation Period? / Revised CDC Forecasts / Dry Heat Guidance / Vaccine Allocation (Nov. 29) (Free)